Montanaro Asset Management LTD Catalent, Inc. Transaction History

Montanaro Asset Management LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$72.36 - $113.1 $2.46 Million - $3.85 Million	34,000 Added 21.45%	192,500 $14 Million
Q2 2022 Aug 05, 2022	BUY	$87.2 - $114.05 $4.88 Million - $6.39 Million	56,000 Added 54.63%	158,500 $17 Million
Q1 2022 May 12, 2022	BUY	$94.19 - $124.49 $9.65 Million - $12.8 Million	102,500 New	102,500 $11.4 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.9B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Montanaro Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Montanaro Asset Management LTD with notifications on news.